Image pharmaphorum Editor R&D Strength in numbers: Because having a rare disease isn’t rar... Rare doesn’t mean insignificant – in fact more people live with a rare disease than with cancer and AIDS combined. Event coverage eyeforpharma Barcelona day one Day one: Tuesday 12 March Highlights include: Views & Analysis eyeforpharma barcelona day two Day two: Wednesday 13 March Views & Analysis eyeforpharma barcelona day three Day three: Thursday 14 March Highlights include: Load more results
R&D Strength in numbers: Because having a rare disease isn’t rar... Rare doesn’t mean insignificant – in fact more people live with a rare disease than with cancer and AIDS combined.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.